• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (6)
    • Carteolol
    • Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.
    • Objective assessment of the effects of tumor motion in radiation therapy.
    • Patient Isolators
    • Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis.
    • See All 6 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis.

Chlorolissoclimides: new inhibitors of eukaryotic protein synthesis. RNA. 2006 May; 12(5):717-25.

View in: PubMed

subject areas
  • Animals
  • Dose-Response Relationship, Drug
  • Eukaryotic Cells
  • HeLa Cells
  • Humans
  • In Vitro Techniques
  • Inhibitory Concentration 50
  • Molecular Structure
  • Mollusca
  • Nuclear Proteins
  • Peptide Chain Elongation, Translational
  • Peptide Elongation Factor 2
  • Peptides, Cyclic
  • Protein Biosynthesis
  • Protein Synthesis Inhibitors
  • Puromycin
  • Ribosomes
  • RNA, Messenger
  • RNA, Transfer, Phe
  • Transcription Factors

authors with profiles
  • Mark T. Hamann